Johnson & Johnson Announces Spin-off of Orthopaedics Business to Form Independent DePuy Synthes Company

Gelonghui October 14 | Johnson & Johnson (JNJ), a multinational company, announced plans to spin off its orthopedics business to enhance strategic and operational focus for each company and create value for shareholders. The transaction will establish an independently operated orthopedics business under the name DePuy Synthes. Upon completion of the split, Johnson & Johnson will focus on six key growth areas: oncology, immunology, neuroscience, cardiovascular, surgery, and vision.